Clinical features and predictive markers of disease progression in cynomolgus monkeys experimentally infected with simian immunodeficiency virus

AIDS. 1992 Mar;6(3):257-63. doi: 10.1097/00002030-199203000-00002.

Abstract

Objective: To study the pathogenicity of simian immunodeficiency virus (SIVsm) in cynomolgus monkeys in order to establish an animal model for human AIDS.

Methods: Thirty-three cynomolgus monkeys were monitored for more than 2 years following experimental infection with SIVsm.

Results: All the macaques became SIV-infected, as demonstrated by virus recovery from peripheral blood lymphocytes and by the appearance of viral antibodies. SIVsm was found to be pathogenic, killing 29 out of the 33 monkeys (88%) within 26 months. Clinically, infected monkeys developed lymphadenopathy, splenomegaly, diarrhoea, weight loss, neurological symptoms and a remarkably high incidence (39%) of malignant lymphomas. All lymphomas were high-grade malignant and of B-cell origin. Disease progression was associated with low CD4+ lymphocyte count, involution of initially hyperplastic follicular B-cell areas in lymph nodes, reappearance of viral antigen in serum, loss of anti-Gag antibodies and development of systemic giant cell disease in 55% of the monkeys.

Conclusions: There are many similarities between SIVsm-induced AIDS in cynomolgus monkeys and human AIDS with regard to clinical, virological, immunological and pathological manifestations.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acquired Immunodeficiency Syndrome*
  • Animals
  • Antibodies, Viral / blood
  • Antigens, Viral / blood
  • CD4-Positive T-Lymphocytes
  • Disease Models, Animal*
  • HIV Infections
  • Leukocyte Count
  • Lymph Nodes / pathology
  • Lymphoma, B-Cell / etiology
  • Macaca fascicularis / microbiology*
  • Prognosis
  • Simian Acquired Immunodeficiency Syndrome* / immunology
  • Simian Acquired Immunodeficiency Syndrome* / microbiology
  • Simian Acquired Immunodeficiency Syndrome* / pathology
  • Simian Immunodeficiency Virus / immunology
  • Simian Immunodeficiency Virus / isolation & purification

Substances

  • Antibodies, Viral
  • Antigens, Viral